[1]Locationinpatent:experimentalpartDevi,Aarti;Shallu;Sharma;Singh,Jasvinder[SyntheticCommunications,2012,vol.42,#10,p.1480-1488]
[2]Shaibuna;Theresa,LetcyV.;Sreekumar[CatalysisLetters,2018,vol.148,#8,p.2359-2372]
[3]Zhu,Weixing;Groh,Matthias;Haupenthal,Jörg;Hartmann,RolfW.[Chemistry-AEuropeanJournal,2013,vol.19,#26,p.8397-8400]
[4]Locationinpatent:experimentalpartLiu,Kun;Lu,Hong;Hou,Ling;Qi,Zhi;Teixeira,Cátia;Barbault,Florent;Fan,Bo-Tao;Liu,Shuwen;Jiang,Shibo;Xie,Lan[JournalofMedicinalChemistry,2008,vol.51,#24,p.7843-7854]
[5]Paal;Schneider[ChemischeBerichte,1886,vol.19,p.558]
[6]Hazlewoodetal.[JournalandProceedings-RoyalSocietyofNewSouthWales,1937,vol.71,p.92,101]
Title: A comprehensive strategy to discover inhibitors of the translesion synthesis DNA polymerase κ.
Journal: PloS one 20120101
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: Design, synthesis, and biological evaluation of N-carboxyphenylpyrrole derivatives as potent HIV fusion inhibitors targeting gp41.
Journal: Journal of medicinal chemistry 20081225
Title: Identification of non-nucleoside DNA synthesis inhibitors of vaccinia virus by high-throughput screening.
Journal: Journal of medicinal chemistry 20081023
Title: Molecular modeling studies of N-substituted pyrrole derivatives--potential HIV-1 gp41 inhibitors.
Journal: Bioorganic & medicinal chemistry 20080315